Home
Institutions
Filings
Issuers
About
All
Index / Passive
Hedge Fund
VC / PE / Holdco
Long-Term Concentrated
Concentrated Active
Quant / Systematic
Diversified Active
XERIS BIOPHARMA HOLDINGS INC
CUSIP: 98422E107
Class: COM
MetLife Investment Management, LLC's Holding History (CIK: 0001529735)
Note: Option positions (PUT/CALL) are excluded.
Q4 2025
Shares
81,594
Value ($000)
$641
Avg Close
—
Range
—
Q3 2025
Shares
87,318
Value ($000)
$711
Avg Close
—
Range
—
Q2 2025
Shares
87,318
Value ($000)
$408
Avg Close
—
Range
—
Q2 2023
Shares
71,237
Value ($000)
$187
Avg Close
—
Range
—
Period
Shares
Value ($000)
Average Close
Price Range
Q4 2025
81,594
$641
—
—
Q3 2025
87,318
$711
—
—
Q2 2025
87,318
$408
—
—
Q2 2023
71,237
$187
—
—